Commonwealth Bank of Australia increased its holdings in Clorox Company (The) (NYSE:CLX) by 0.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,312 shares of the company’s stock after purchasing an additional 96 shares during the period. Commonwealth Bank of Australia’s holdings in Clorox Company (The) were worth $1,506,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. American Beacon Advisors Inc. purchased a new stake in shares of Clorox Company (The) in the first quarter valued at $104,000. Parkside Financial Bank & Trust grew its position in shares of Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after purchasing an additional 29 shares during the period. Valley National Advisers Inc. grew its position in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after purchasing an additional 5 shares during the period. Blue Chip Partners Inc. grew its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after purchasing an additional 6 shares during the period. Finally, Zions Bancorporation grew its position in shares of Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock valued at $134,000 after purchasing an additional 53 shares during the period. 71.28% of the stock is owned by institutional investors and hedge funds.

In related news, COO Dawn C. Willoughby sold 2,158 shares of the stock in a transaction on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total transaction of $297,804.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP James E. Foster sold 9,861 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total value of $1,365,847.11. Following the sale, the executive vice president now owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 21,242 shares of company stock valued at $2,944,449. 0.74% of the stock is owned by corporate insiders.

A number of equities research analysts have recently commented on the company. Jefferies Group LLC reaffirmed a “hold” rating and issued a $137.00 price objective (up previously from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. Barclays PLC reaffirmed an “equal weight” rating and issued a $136.00 price objective (down previously from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. BMO Capital Markets set a $150.00 price objective on Clorox Company (The) and gave the company a “buy” rating in a research report on Thursday, August 3rd. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and issued a $115.00 price objective on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company’s stock. Clorox Company (The) presently has a consensus rating of “Hold” and a consensus price target of $129.05.

Shares of Clorox Company (NYSE CLX) opened at 134.08 on Thursday. The firm’s 50-day moving average price is $135.79 and its 200-day moving average price is $135.26. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The stock has a market cap of $17.31 billion, a P/E ratio of 25.13 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same period last year, the company earned $1.30 earnings per share. Clorox Company (The)’s quarterly revenue was up 2.9% compared to the same quarter last year. On average, equities research analysts forecast that Clorox Company will post $5.66 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was first posted by Daily Political and is owned by of Daily Political. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://www.dailypolitical.com/2017/09/14/clorox-company-the-clx-stake-raised-by-commonwealth-bank-of-australia.html.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.